Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GNRH Receptor
    (4)
  • PERK
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Reproductive system
    (2)
  • Cancer
    (1)
Filter
Search Result
Results for "

gnrh i

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | All_Pathways
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
GnRH-I
TP1342
GnRH-I is a small 10 amino acid long peptide (decapeptide) from the hypothalamus,It is also known as luteinizing hormone releasing hormone (LHRH), is a key molecule in the regulation of reproduction in vertebrates. GnRH, a decapeptide, is produced by neur
  • $58
Inquiry
Size
QTY
GnRH-I acetate
GnRH-I acetate(33515-09-2 free base)
TP1342L
GnRH-I acetate in release of biologically active Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in the blood.
  • $68
In Stock
Size
QTY
LGnRH-III, lamprey
TP1700147859-97-0
GnRH III, an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.
  • Inquiry Price
Inquiry
Size
QTY
LGnRH-III, lamprey acetate(147859-97-0 free base)
TP1700L
LGnRH-III, lamprey acetate is an evolutionarily conserved member of the GnRH family, can stimulate the secretion of gonadotropins, it stimulates the secretion of both luteinizing and follicle-stimulating hormones.
  • $80
In Stock
Size
QTY
Triptorelin
[DTrp6]-LH-RH
T3637157773-63-4
Triptorelin ([DTrp6]-LH-RH) is an analog of gonadotropin-releasing hormone (GnRH) and a high-affinity GnRH receptor agonist that stimulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
  • $63
In Stock
Size
QTY
NBI-42902
T69383352290-60-9
NBI-42902 is a potent inhibitor of peptide radioligand binding to the human GnRH receptor (K(i) = 0.56 nm). Tritiated NBI-42902 binds with high affinity (K(d) = 0.19 nm) to a single class of binding sites and can be displaced by a range of peptide and nonpeptide GnRH receptor ligands. In vitro experiments demonstrate that NBI-42902 is a potent functional, competitive antagonist of GnRH stimulated IP accumulation, Ca(2+) flux, and ERK1/2 activation. It did not stimulate histamine release from rat peritoneal mast cells. Finally, it is effective in lowering serum LH in castrated male macaques after oral administration. Overall, these data provide a benchmark of pharmacological characteristics required for a nonpeptide GnRH antagonist to effectively suppress gonadotropins in humans and suggest that NBI-42902 may have clinical utility as an oral agent for suppression of the hypothalamic-pituitary-gonadal axis. (source: Endocrinology. 2007 Feb;148(2):857-67. Epub 2006 Nov 9.)
  • $1,310
6-8 weeks
Size
QTY